French Glendon E. III 4
4 · Pulmonx Corp · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Pulmonx CorpLUNG
French Glendon E. III
DirectorPresident and CEO
Transactions
- Sale
Common Stock
[F1]2026-03-02$1.43/sh−2,708$3,872→ 1,474,616 total - Sale
Common Stock
[F2]2026-03-02$1.43/sh−6,737$9,634→ 1,467,879 total - Sale
Common Stock
[F3]2026-03-02$1.43/sh−58,368$83,466→ 1,409,511 total
Holdings
- 742,998(indirect: By Trust)
Common Stock
[F4]
Footnotes (4)
- [F1]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2022.
- [F2]These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
- [F3]Represents grant of RSUs payable solely in common stock of the Issuer that vests in equal quarterly installments over the three-year period following the date of grant of December 1, 2025.
- [F4]The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.
Signature
/s/ David Aaron Lehman, Attorney-in-Fact|2026-03-04